LifeStance Health Group, Inc. (LFST)
NASDAQ: LFST · Real-Time Price · USD
12.93
+0.37 (2.95%)
At close: Oct 23, 2026, 4:00 PM EDT
12.87
-0.06 (-0.46%)
After-hours: Oct 23, 2026, 7:30 PM EDT
LifeStance Health Group Stock Forecast
Stock Price Forecast
According to 11 analysts polled by S&P Global, LifeStance Health Group stock has a consensus rating of "Buy" and an average price target of $14.4. The average 1-year stock price forecast is 11.37% higher than the current stock price, while the lowest is $12 (-7.19%) and the highest is $18 (+39.21%).
Price Target: $14.4 (+11.37%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for LifeStance Health Group stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | May '26 | Jun '26 | Jul '26 | Aug '26 | Sep '26 | Oct '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 7 | 7 | 7 | 7 | 7 | 7 |
| Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Hold | 1 | 2 | 2 | 2 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 10 | 11 | 11 | 11 | 11 | 11 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Canaccord Genuity | Canaccord Genuity | Buy Maintains $15 | Buy | Maintains | $15 | +16.01% | Oct 15, 2026 |
| KeyBanc | KeyBanc | Buy Maintains $15 | Buy | Maintains | $15 | +16.01% | Oct 5, 2026 |
| Jefferies | Jefferies | Buy Maintains $14 → $15 | Buy | Maintains | $14 → $15 | +16.01% | Sep 25, 2026 |
| Barclays | Barclays | Buy Maintains $13 → $15 | Buy | Maintains | $13 → $15 | +16.01% | Sep 10, 2026 |
| William Blair | William Blair | Buy Reiterates n/a | Buy | Reiterates | n/a | n/a | Aug 21, 2026 |
Financial Forecast
Revenue This Year
1.71B
from 1.42B
Increased by 19.96%
Revenue Next Year
1.96B
from 1.71B
Increased by 14.48%
EPS This Year
0.36
from 0.18
Increased by 97.10%
EPS Next Year
0.43
from 0.36
Increased by 19.82%
EPS and Forward PE are based on non-GAAP adjusted numbers.